HuGE Literature Finder
Records
1
-
4
| A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection. Journal of translational medicine 2020 Jun 18 (1): 232. Velázquez Carolina, Lastra Enrique, Avila Cobos Francisco, Abella Luis, de la Cruz Virginia, Hernando Blanca Ascensión, Hernández Lara, Martínez Noemí, Infante Mar, Durán Merced |
| Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients. Cancers 2018 Nov 10 (11): . Koczkowska Magdalena, Krawczynska Natalia, Stukan Maciej, Kuzniacka Alina, Brozek Izabela, Sniadecki Marcin, Debniak Jaroslaw, Wydra Dariusz, Biernat Wojciech, Kozlowski Piotr, Limon Janusz, Wasag Bartosz, Ratajska Magdale |
| High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
| Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast cancer research and treatment 2014 Jun 145 (2): 553-62. Sokolenko Anna P, Bogdanova Natalia, Kluzniak Wojciech, Preobrazhenskaya Elena V, Kuligina Ekatherina S, Iyevleva Aglaya G, Aleksakhina Svetlana N, Mitiushkina Natalia V, Gorodnova Tatiana V, Bessonov Alexandr A, Togo Alexandr V, Lubi?ski Jan, Cybulski Cezary, Jakubowska Anna, Dörk Thilo, Imyanitov Evgeny |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: